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Background: MRI brain changes in Parkinson’s disease (PD) are controversial.
Objectives: We aimed to describe structural and functional changes in PD.
Methods: Sixty-six patients with PD (57.94 ±  10.25  years) diagnosed according to 
the UK Brain Bank criteria were included. We performed a whole brain analysis using 
voxel-based morphometry (VBM–SPM 8 software), cortical thickness (CT) using CIVET, 
and resting-state fMRI using the Neuroimaging Analysis Kit software to compare patients 
and controls. For VBM and CT we classified subjects into three groups according to 
disease severity: mild PD [Hoehn and Yahr scale (HY) 1–1.5], moderate PD (HY 2–2.5), 
and severe PD (HY 3–5).
results: We observed gray matter atrophy in the insula and inferior frontal gyrus in the 
moderate PD and in the insula, frontal gyrus, putamen, cingulated, and paracingulate 
gyri in the severe groups. In the CT analysis, in mild PD, cortical thinning was restricted to 
the superior temporal gyrus, gyrus rectus, and olfactory cortex; in the moderate group, 
the postcentral gyrus, supplementary motor area, and inferior frontal gyrus were also 
affected; in the severe PD, areas such as the precentral and postentral gyrus, temporal 
pole, fusiform, and occipital gyrus had reduced cortical thinning. We observed altered 
connectivity at the default mode, visual, sensorimotor, and cerebellar networks.
conclusion: Subjects with mild symptoms already have cortical involvement; however, 
further cerebral involvement seems to follow Braak’s proposed mechanism. Similar 
regions are affected both structurally and functionally. We believe the combination of 
different MRI techniques may be useful in evaluating progressive brain involvement and 
they may eventually be used as surrogate markers of disease progression.
Keywords: Parkinson’s disease, neuroimaging, cortical thickness, functional Mri, voxel-based morphometry
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highlighTs
•	 Subjects	 with	mild	 symptoms	 already	 have	 cortical	 involve-
ment;	however,	further	cerebral	involvement	seems	to	follow	
Braak’s	proposed	mechanism.
•	 Similar	brain	regions	are	affected	both	structurally	and	func-
tionally,	such	as	temporal,	frontal,	and	occipital	gyri;	however,	
it	 is	 still	unclear	 if	 functional	alterations	are	consequence	or	
direct	cause	of	structural	ones	or	if	they	occur	simultaneously.
inTrODUcTiOn
Parkinson’s	disease	(PD)	is	a	progressive	neurodegenerative	dis-
order	(1).	Considering	the	variability	of	symptoms	and	the	still	
unknown	 etiology,	MRI-based	 studies	 are	 important	 to	 better	
understand	disease	physiopathology.
Voxel-based	morphometry	 (VBM)	 (2)	 assesses	 gray	 matter	
(GM)	density	or	volume,	voxel	by	voxel.	A	meta-analysis	revealed	
GM	atrophy	in	the	left	inferior	frontal	gyrus,	left	superior	tempo-
ral	gyrus	and	left	insula	in	patients	with	idiopathic	PD	(3).	Only	
two	 studies	 evaluated	 disease	 progression	 as	 measured	 by	 the	
Hoehn	and	Yahr	 scale	 (HY),	and	 their	outcomes	differed.	One	
revealed	minimal	statistically	significant	GM	reduction	(4),	while	
the	other	described	atrophy	in	olfactory-related	regions	(5).
Cortical	 thickness	 (CT)	analysis	 is	needed	 to	assess	 cortical	
surface	properties	(6)	for	it	allows	subvoxel	precision,	as	thick-
ness	values	are	assigned	to	 individual	vertices	(7).	CT	is	useful	
to	 investigate	 subtle	cortical	 changes	 in	 the	brain	 (8).	Previous	
studies	 using	 CT	 in	 PD	 demonstrated	 widespread	 alterations	
(9–11),	nonetheless	a	clear	pattern	was	not	established.
Resting-state	functional	MRI	(rs-fMRI)	evaluates	regional	and	
neuronal	circuitry	at	rest	(12),	as	it	measures	functional	connec-
tivity	 (FC)	 in	spatially	distinctive	regions	 (13).	 rs-fMRI	studies	
in	 PD	 found	 altered	 connectivity	 in	 the	 cerebellum,	 primary	
motor	cortex,	supplementary	motor	area	(SMA),	dorsolateral	and	
prefrontal	cortex,	and	putamen	(4).
Wu	et al.,	using	FC	global	measure	through	graphical	analy-
sis,	found	increased	coupling	in	the	cortex	and	cerebellum	and	
primary	motor	 cortex,	 and	decreased	FC	 in	SMA,	dorsolateral	
and	prefrontal	cortex,	and	putamen.	It	is	noteworthy	that	these	
results	are	consistent	with	the	altered	pattern	of	metabolic	brain	
activity	found	in	PD	using	positron	emission	tomography	(14).	
Decreased	 FC	 in	 a	 circuit	 connecting	 posterior	 putamen	with	
the	 inferior	parietal	cortex	as	well	as	an	 increased	FC	between	
subthalamic	nuclei	and	cortical	motor	areas	were	also	described,	
indicating	 abnormalities	 in	 sensorimotor	 integration	 and	 sug-
gesting	that	some	symptoms,	such	as	tremor,	may	be	related	to	
an	abnormal	coupling	of	these	areas	(15,	16).
Alterations	in	CT	have	also	been	demonstrated	in	PD	patients	
in	multiple	brain	regions,	such	as	occipital,	temporal,	and	frontal	
cortices	(10,	17).	Pereira	et al.	demonstrated	a	widespread	cortical	
thinning	 in	 lateral	occipital,	parietal	 and	 temporal,	 frontal	 and	
premotor	regions.
Cortical	 thickness	 measure	 is	 a	 valuable	 tool	 for	 it	 allows	
subvoxel	 precision	 because	 thickness	 values	 are	 assigned	 to	
individual	vertices	instead	of	voxels	(7,	9).
Despite	 the	 progress	 obtained	 in	 the	 last	 30  years	 trying	 to	
comprehend	PD	pathophysiology,	several	questions	remain.
In	 general,	 neuroimaging	 studies	 in	 PD	 compare	 patients	
with	or	without	certain	disorders,	such	as	dementia	and	depres-
sion,	but	do	not	consider	associated	clinical	markers	like	motor	
symptoms	severity,	other	non-motor	symptoms,	or	the	presence	
of	motor	complications	(10,	18).
Furthermore,	despite	the	large	number	of	validated	scales	for	
clinical	evaluation	in	PD	patients,	there	are	few	studies	correlat-
ing	them	with	MRI	findings.
One	of	the	greatest	challenges	nowadays	in	PD	is	the	absence	
of	 biomarkers	 for	 disease	 diagnosis	 in	 premotor	 stages	 and	
differential	 diagnosis	 with	 other	 neurodegenerative	 causes	 of	
parkinsonism.	Thus,	our	purpose	was	to	systematically	evaluate	
patients	 with	 PD	 from	 clinical	 and	 neuroimaging	 data	 using	
rs-fMRI	 and	CT	analyzes.	However,	 our	 focus	was	 to	 generate	
hypotheses	based	 in	 this	preliminary	 study,	 and	 a	 longitudinal	
study	 is	already	under	way	 in	order	 to	confirm	the	findings	 in	
this	paper.
MaTerials anD MeThODs
Cross-sectional	 study	 was	 conducted	 at	 the	 Neuroimaging	
Laboratory—Unicamp	 University	 Hospital	 and	 McConnel	
Brain	 Imaging	Center—Montreal	Neurological	 Institute	 (MNI)	
(McGill	 University).	 The	 State	 University	 of	 Campinas	 Ethics	
Committee	 approved	 the	 study,	 and	 all	 individuals	 signed	 an	
informed	written	consent	prior	to	any	research	related	procedure.	
All	images	were	acquired	at	UNICAMP	University	Hospital	and	
MRI	analysis	was	performed	at	MNI.
subjects
Sixty-six	 patients	 (57.94  ±  10.25  years)	 (43	 men)	 older	 than	
30  years	 with	 PD,	 diagnosed	 according	 to	 the	UK	 Parkinson’s	
Disease	 Society	 Brain	 Bank	 criteria	 (19)	 were	 consecutively	
recruited	 from	 the	 Movement	 Disorders	 Outpatient	 Clinic	 of	
the	 University	 Hospital	 (UNICAMP),	 Brazil,	 and	 underwent	
MRI	(Table 1).	In	46,	we	performed	the	whole	clinical	protocol,	
including	the	clinical	scales.	An	experienced	neurologist	special-
ized	in	Movement	Disorders	assessed	all	patients.
Evaluation	consisted	of	a	standardized	questionnaire	regard-
ing	 sex,	 age,	 age	 at	 disease	 onset,	 family	 history,	 professional	
history,	environmental	exposure	to	risk	factors,	and	medication	
used,	as	well	as	the	application	of	the	Unified	Parkinson	Disease	
Rating	Scale	(UPDRS),	HY,	Scales	for	Outcomes	in	Parkinson’s	
Disease—Cognition	 (SCOPA-COG),	 Schwab	 and	 England	
Activities	of	Daily	Living,	and	Non-Motor	Symptom	Assessment	
Scale	(NMSS)	(Table 1).	All	patients	were	on	medication	on	clini-
cal	assessment	and	the	MRI	acquisition.
We	also	 included	40	healthy	controls	 (HC),	with	no	history	
of	neurological	disorders,	no	family	history	of	PD,	and	a	normal	
neurological	examination	(mean	age	57.60 ± 10.77).
For	 VBM	 and	 CT,	 we	 classified	 subjects	 into	 three	 groups	
according	to	disease	severity:	mild	PD	(HY	1–1.5),	moderate	PD	
(HY	2–2.5),	and	severe	PD	(HY	3–5)	(Table 1).
We	performed	VBM	analysis	in	66	patients	and	40	HC.	Eight	
patients	 were	 excluded	 from	 the	 CT	 analysis	 due	 to	 excessive	
TaBle 1 | Demographic data from all Parkinson’s disease (PD) patients, mild PD, moderate PD, and severe PD.
all PD Mild PD Moderate PD severe PD
clinical data Mean sD Mean sD Mean sD Mean sD
Age 59.33 9.8 59.31 9.60 58.5 10.69 62.07 8.4
Education 6.9 4.7 8.05 4.30 7.05 5.01 4.84 3.3
Unified Parkinson’s Disease Rating Scale (UPDRS) 35.74 18.47 20.94 8.86 34 13.38 63.21 17.15
UPDRS-III 16.93 8.23 10.88 78 16.2 5.95 28.35 8.88
Hoehn and Yahr scale 2.8 1.26 1.25 0.25 2.57 0.3 4.42 0.51
Scales for Outcomes in Parkinson’s Disease—Cognition (SCOPA-COG) 19.24 6.8 21.66 3.77 19.69 7.18 13.28 7.15
SCOPA-CP 3.6 7.8 1.55 1.72 2.77 2.37 10.07 18.63
NMSS 69.57 48.19 42.72 34.97 71.61 46.95 96.53 52.43
SCHWAB (%) 73 22 88 8 76 15 34 22
Time of disease 7 6.43 2.5 4.08 7 6.62 12.14 5.31
Medication 5.4 5.7 2.5 1.9 3 2.6 9.5 6.8
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head	movement	or	the	presence	of	artifacts.	The	fMRI	acquisi-
tion	protocol	was	included	after	the	initial	recruitment,	so	only	
48	patients	and	33	HC	had	available	images.
Mri acquisition
Patients	and	HC	underwent	the	same	MRI	acquisition	protocol	
on	a	3-T	Philips	Achieva;	MRI	scanner	at	UNICAMP:
	(1)		 Echo-planar	 imaging	 sequences	 of	 6  min	 with	 iso-
tropic	voxel	of	 3 mm ×  3 mm ×  3 mm,	no	gap,	 39	 slices,	
FOV = 240 mm × 240 mm,	TE = 30 ms,	TR = 2000 ms,	flip	
angle = 90°,	and	180	volumes	(dynamics),	in	a	6-min	scan;
	(2)		 Volumetric	 (3D)	 T1	 WI,	 acquired	 in	 the	 sagittal	 plane	
with	 isotropic	 voxel	 with	 1mm3,	 no	 gap,	 flip	 angle =  35°,	
TR = 7.1 ms,	TE = 3.2 ms,	FOV = 240 mm × 240 mm,	in	a	
6-min	scan.
VBM analysis
We	used	 the	VBM8	 toolbox	 of	 the	 statistical	 parametric	map-
ping	 (SPM8)1	 and	 the	Diffeomorphic	 Anatomical	 Registration	
Exponentiated	Lie	Algebra	(Dartel)	software	on	Matlab	R2012b	
platform	to	process	and	analyze	the	images.	VBM	allows	a	voxel-
wise	 comparison	of	 local	GM	differences	between	 two	groups.	
VBM	procedure	involves	the	segmentation	of	the	original	struc-
tural	MRI	 images	 in	native	 space	 in	GM,	white	matter	 (WM),	
and	cerebrospinal	fluid	(CSF)	tissues,	followed	by	GM	and	WM	
images	normalization	to	templates	in	stereotactic	space	to	acquire	
optimized	 normalization	 parameters,	 which	 are	 applied	 to	 the	
raw	images.	GM	images	were	smoothed	using	an	8-mm	full	width	
at	 half	maximum	 (FWHM)	 isotropic	Gaussian	 kernel.	 Finally,	
we	employed	a	general	 linear	model	(GLM),	using	age	and	sex	
as	 covariates.	We	 obtained	 the	 results	 showing	 regions	 of	GM	
concentration	 with	 significant	 differences	 between	 the	 groups	
(20).	 Correction	 for	 multiple	 comparisons	 used	 the	 Random	
Fields	Theory	(RFT).	In	each	group	analysis,	a	homogeneity	test	
using	covariance	led	to	the	exclusion	of:	five	patients	(PD	versus	
HC);	one	patient	and	one	HC	(mild	PD	versus	HC);	three	patients	
1	http://www.fil.ion.ucl.ac.uk/spm.
and	one	HC	(moderate	PD	versus	HC);	and	five	patients	and	one	
HC	 (severe	 PD	 versus	 HC).	The	 results	 were	 displayed	 using	
SPM8	and	xjView	(Human	Neuroimaging	Lab,	Baylor	College	of	
Medicine,	Houston,	TX,	USA).	We	assessed	group	comparisons	
by	 SPM	 using	 the	 family	 wise	 error	 (FWE)	 at	 a	 threshold	 of	
p < 0.05,	covariates	were	sex	and	age,	with	an	extent	threshold	of	
K = 20	voxels	and	clusters	>30	voxels.	Brain	areas	were	localized	
according	to	the	automated	anatomical	labeling	available	on	The	
Online	Brain	Atlas	Reconciliation	Tool	(21).
cT analysis
Excessive	 head	 movement	 or	 the	 presence	 of	 artifacts	 led	 to	
the	exclusion	of	subjects.	We	used	the	fully	automated	pipeline	
CIVET	(version	1.1.10;	MNI	at	McGill	University,	Montreal,	QC,	
Canada)	to	estimate	CT.	Since	the	fMRI	acquisition	protocol	was	
also	included	after	the	initial	recruitment,	48	patients	and	33	HC	
had	available	images.
In	summary,	it	consists	of:	correction	for	magnetic	inhomo-
geneity,	skull	stripping,	linear,	and	non-linear	registration	of	the	
native	image	to	the	symmetric	ICBM	152	template;	tissue	classi-
fication	into	GM,	WM,	and	CSF,	corrected	for	the	partial	volume	
effect;	GM	and	WM	surfaces	are	extracted	using	the	Laplacian	
map;	thickness	is	calculated	at	each	vertex	using	the	t-	link	metric	
method.	CT	is	estimated	as	the	distance,	in	millimeters,	between	
WM	and	GM	surfaces	at	each	vertex.	More	details	on	this	tech-
nique	can	be	found	on	the	CIVET	website.2	For	this	analysis,	we	
regressed	out	age.	We	also	correlated	scales	scores	with	CT	from	
all	PD	patients.
After	 that,	we	stratified	patients	 into	mild	(n = 16),	moder-
ate	 (n =  21),	 and	 severe	 PD	 (n =  11)	 and	 compared	 them	 to	
HC.	Statistical	analysis	was	performed	 in	Matlab	(R2008b,	The	
Mathworks,	Natick,	MA,	USA),	using	the	SurfStat	toolbox.3	We	
performed	 a	GLM	 to	 describe	CT	 as	 a	 combination	 of	 demo-
graphic	variables	 such	as	 age,	 group	 (PD	or	HC),	 and	 sex.	We	
used	p < 0.05	(RTF).
2	http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET.
3	http://www.math.mcgill.ca/keith/surfstat/.
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rs-fMri analysis
The	 fMRI	 data	 were	 preprocessed	 using	 the	 Neuroimaging	
Analysis	Kit	(NIAK)	release	0.7	(22).4	The	first	three	volumes	
of	each	run	were	omitted	to	allow	the	magnetization	to	reach	
equilibrium.	Each	fMRI	dataset	was	corrected	for	inter-slice	dif-
ferences	in	acquisition	time	and	the	parameters	of	a	rigid-body	
motion	were	estimated	for	each	time	frame.	Rigid-body	motion	
was	then	estimated	between	runs.	The	median	volume	of	the	
first	run	for	each	subject	was	co-registered	with	a	T1	individual	
scan	(23),	which	was	itself	non-	linearly	transformed	to	MNI	
space,	using	the	latest	version	of	the	ICBM152	template	(24).	
The	 transformations	 fMRI-to-T1	 and	 T1-to-stereotaxic	 were	
concatenated,	 to	 resample	 the	 functional	 volumes	 into	MNI	
space	at	a	3-mm	isotropic	resolution.	The	“scrubbing”	method	
of	Power	et al.	(25),	was	used	to	remove	volumes	with	exces-
sive	motion.	The	fMRI	volumes	were	spatially	smoothed	with	
a	 6-mm	 isotropic	Gaussian	blurring	 kernel.	A	more	detailed	
description	 of	 the	 pipeline	 can	 be	 found	 at:	 https://github.
com/ulrikls/niak.	We	performed	a	Bootstrap	analysis	of	stable	
clusters	(BASC).	It	consists	in	studying	the	stability	of	networks	
detected	with	 iterative	operations	of	clustering.	The	resulting	
stability	matrix	is	used	in	a	clustering	procedure,	which	derives	
so-called	 stable	 clusters.	 BASC	 is	 first	 applied	 on	 individual	
fMRI	time	series,	and	applying	a	Circular	Block	Bootstrap	to	
fMRI	 time	 series	 derives	 replications	 of	 clustering.	 A	 stabil-
ity	matrix	 is	derived	 for	each	subject.	The	average	 individual	
stability	matrix	is	then	computed	and	a	hierarchical	clustering	
is	applied	on	it.	This	allows	defining	group-level	clusters	that	
maximize	the	average	probability	of	being	clustered	at	the	indi-
vidual	level.	By	bootstrapping	the	subject	stability	matrices,	the	
group-level	stability	matrix	is	derived.	A hierarchical	clustering	
is	finally	applied	on	the	group	stability	matrix	to	define	stable	
group	clusters.	For	each	brain	region,	 the	average	stability	of	
that	region	with	every	other	region	in	the	cluster	of	 the	seed	
can	be	derived.
We	excluded	patients	with	excessive	head	movement,	since	it	
could	result	in	spurious	observations;	however,	little	head	move-
ment	was	accepted	(frame	displacement	lower	than	0.2).
Statistical	 analysis	 was	 performed	 in	 Matlab	 (R2008b,	 The	
Mathworks,	Natick,	MA,	USA).	We	performed	a	GLM	to	describe	
connectivity	 as	 a	 combination	 of	 variables	 such	 as	 age,	 group	
(PD	or	HC),	sex,	with	head	motion	as	a	covariate.	We	selected	
a	p < 0.05.
statistical analysis
For	statistical	analysis,	we	used	STATA	13.1	version.	We	compared	
baseline	demographic	characteristic	using	a	one-way	Analysis	of	
Variance,	without	 covariates,	 followed	by	a	post hoc	 Sidak	 test.	
For	categorical	variables,	we	performed	a	chi-square	test.	For	cor-
relation	analyses,	we	perform	a	GLM,	including	the	scales	scores	
as	independent	variables	and	sex	and	age	as	covariates.	Level	of	
significance	was	established	at	p < 0.05.
4	https://github.com/ulrikls/niak.
resUlTs
Voxel-Based Morphometry
Mild	 PD	 (n =  14)	 versus	HC:	 there	was	 no	GM	 reduction	 in	
any	 region	 (FWE	p <  0.05)	 (Figure  1;	Table  2).	Moderate	PD	
(n = 31)	versus	HC:	VBM	detected	GM	loss	in	the	left	insula	and	
left	inferior	frontal	gyrus,	opercular	part	(FWE	p < 0.05).	Severe	
PD	 (n =  16)	 versus	HC:	 we	 observed	GM	 atrophy	 in	 the	 left	
insula,	left	inferior	frontal	gyrus	(opercular	part),	left	putamen,	
left	and	right	medial	superior	frontal	gyrus,	left	and	right	anterior	
cingulate	 and	paracingulate	 gyri,	 and	 right	median	 cingulated,	
and	paracingulate	gyri	(FWE	p < 0.05).
cortical Thickness
Mild	PD	(n = 16)	versus	HC:	CT	analysis	revealed	cortical	thin-
ning	in	the	left	superior	temporal	gyrus,	left	gyrus	rectus,	and	left	
olfactory	cortex	(RFT	p < 0.05).	Moderate	PD	(n = 21)	versus	
HC:	 the	areas	with	cortical	 thinning	were	 the	right	postcentral	
gyrus,	right	SMA,	and	right	inferior	frontal	gyrus	(triangular	and	
opercular	parts)	(RFT	p < 0.05)	(Figure 1;	Table 2).	Severe	PD	
(n = 11)	versus	HC:	CT	analysis	revealed	cortical	thinning	in	the	
left	inferior	frontal	gyrus,	 left	precentral	and	postcentral	gyrus,	
left	SMA,	 left	inferior	frontal	gyrus	(triangular	part),	 left	gyrus	
rectus,	 right	 temporal	 pole,	 right	 fusiform	 gyrus,	 right	middle	
temporal	 gyrus,	 and	 right	 occipital	 gyrus	 (RFT	p <  0.05).	We	
found	a	negative	correlation	between	UPDRS	and	CT	in	superior	
temporal	gyrus,	pre	and	post	central	gyrus,	superior	and	inferior	
frontal	gyrus,	SMA,	occipital	gyrus,	and	gyrus	rectus.	The	same	
negative	correlation	was	found	regarding	UPDRS-III	in	superior	
and	medial	temporal	gyrus,	lingual	gyrus,	parahipocampal	gyrus,	
SMA,	and	medial	temporal	gyrus	(p < 0.05).	SCOPA	and	NMSS	
scores	did	not	correlate	with	CT	values.
resting-state Functional Mri
The	final	sample	was	too	small	to	further	subdivide,	so	we	per-
formed	a	whole	brain	analysis,	without	an	a priori	 assumption	
(Figure 2;	Table 3).	Our	main	objective	was	to	demonstrate	by	
cluster	analysis	that	the	resting-state	abnormalities	occur	in	the	
whole	brain	in	PD	patients.	Based	on	data	provided	by	the	BASC	
pipeline,	we	selected	the	scale	with	70	clusters	as	the	most	stable	
one	and	examined	the	networks	found	at	this	scale	(22).	We	found	
reduced	 connectivity	 within	 visual,	 sensorimotor,	 DMN,	 and	
cerebellum	networks.
DiscUssiOn
We	evaluated	PD	patients	using	VBM,	CT,	and	rs-fMRI	analysis	
without	an	a priori	assumption.	GM	volume	and	CT	are	the	two	
most	 widely	 used	 measures	 for	 detecting	 GM	 morphometric	
changes,	but	they	measure	different	aspects	of	 the	brain,	hence	
the	importance	of	performing	both	methods	(8).	We	observed	a	
certain	concurrence	between	VBM	and	CT	findings	within	each	
stage.
One	 region	 with	 decreased	 CT	 in	 mild	 PD	 was	 the	 left	
olfactory	 cortex,	 which	 receives	 sensory	 information	 from	 the	
FigUre 1 | (a,B) show areas with atrophy in moderate PD and severe PD patients when compared to healthy controls (HC), p < 0.05 FEW, (c–e) show area with 
cortical thinking in mild PD, moderate PD, and severe PD, respectively, when compared to HC p < 0.5, Random Fields Theory.
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olfactory	bulb	(26),	which	is	in	keeping	with	the	olfactory	loss	as	
one	of	the	early	non-motor	manifestations	of	PD	as	well	as	with	
previous	findings	of	Lewy	pathology	in	anterior	olfactory	nucleus	
and	olfactory	bulb	(27).	We	did	not	find	the	same	alteration	using	
VBM;	 however,	CT	 analyses	 are	more	 sensitive	 than	VBM	 for	
identifying	regional	cortical	thinning	associated	with	PD	because	
VBM	merges	information	about	morphology,	size,	and	position	
and	the	final	measures	average	information	about	thickness	and	
cortical	folding	(2),	possibly	resulting	in	less	sensitivity.
Olfactory	loss	is	an	important	non-motor	manifestation	in	PD,	
and	it	seems	to	be	present	years	before	diagnosis	(28).	We	could	
not	find	an	association	between	NMSS	scores	and	CT;	however,	
we	used	the	scale	total	score,	and	possibly,	an	assessment	of	each	
scale	domain	is	more	appropriate	for	PD,	especially	in	longitudi-
nal	analysis.	Previous	studies	demonstrated	a	correlation	between	
amygdala	and	hippocampus	volume	with	depression	and	anxiety	
in	PD	patients	 (29);	however,	 these	 symptoms	are	non-specific	
and	can	be	present	in	normal	aging	(30).
The	widely	known	and	accepted	Braak’s	stage	postulates	that	
the	Lewy	body	(LB)	deposition	in	PD	progresses	in	an	ascend-
ing	 fashion	 (31).	 In	 stages	 1	 and	 2,	 it	 is	 essentially	 restricted	
to	 the	 medulla	 oblongata.	 In	 stages	 3	 and	 4,	 the	 involvement	
is	 mostly	 observed	 in	 the	 brain	 stem	 without	 cortical	 lesions	
(stage	3)	or	with	initial	deposition	at	the	anteromedial	temporal	
mesocortex	(stage	4),	while	in	stages	5	and	6,	there	is	inexorable	
cortical	involvement.	Recent	studies	suggest	the	possibility	that	
α-synuclein	 is	 a	 prion-like	 protein	 and	 that	PD	 is	 a	 prion-like	
disease,	 a	 theory	 compatible	 with	 Braak’s	 staging	 system	 (32).	
Other	pathological	studies,	however,	have	clearly	challenged	the	
generalizability	of	this	hypothesis,	and	as	far	as	we	know,	it	has	
not	been	demonstrated	by	in vivo	studies	(33).
Considering	 our	 findings,	 even	 patients	 with	 mild	 motor	
symptoms,	already	have	cortical	involvement	(possibly	stage	4/5),	
while	we	did	not	observe	significant	atrophy	in	the	brainstem.	We	
believe	 this	 is	due	 to	a	 compensatory	mechanism	of	 the	brain,	
where	brain	alterations	are	already	present	but	 there	 is	 still	no	
clinical	symptoms.
The	 further	 progression	 seems	 to	 follow	 the	 previously	
described	 pattern.	 It	 is	 worth	 mentioning,	 nevertheless,	 that	
while	the	Braak’s	stage	takes	LB	depositions	into	consideration,	
imaging	 analyses	 are	mostly	 concerned	with	GM	 loss.	Hence,	
some	 of	 the	 differences	 in	 the	 results	may	 reflect	 the	 variable	
FigUre 2 | reduced functional connectivity (Fc) within visual (a), 
sensorimotor (B), DMn (c), and cerebellum networks (D) in PD 
patients when compared to controls. The areas in yellow have reduced 
FC with areas in blue in PD patients compared to controls at p level 0.05.
TaBle 2 | areas with reduced cortical thickness (cT) on the left and gM atrophy on the right of mild Parkinson’s disease (PD) versus healthy controls 
(hc), moderate PD versus hc and severe PD versus hc (p < 0.05).
cT Voxel-based morphometry
coordinates (x y z) areas p [random fields Theory (rFT)] coordinates (x y z) areas p (rFT)
Mild PD
−48 −11 0 L superior Temporal Gyrus <0.05 – – –
−9 31 −21 Gyrus rectus <0.05 – – –
−21 9 −18 L superior frontal gyrus <0.05 – – –
−16 6 −16 L olfactory cortex <0.05 – – –
55 −16 46 R post central gyrus <0.05 – – –
Moderate PD
14 1 69 Supplementary motor area (SMA) <0.05 −30 14 9 L insula <0.05
53 25 9 Inferior frontal gyrus <0.05 −30 14 9 L inferior frontal gyrus <0.05
16 0 71 R superior frontal Gyrus <0.05
severe PD
−41 21 9 L inferior frontal gyrus <0.05 −35 14 3 L insula <0.05
−64 -12 17 L postcentral gyrus <0.05 −35 14 3 L inferior frontal gyrus <0.05
35 −10 −38 Fusiform gyrus <0.05 −35 14 3 L putamen <0.05
−29 −15 70 L precentral gyrus <0.05 0 41 25 R superior frontal gyrus <0.05
−9 −1 70 L SMA <0.05 0 41 25 Anterior cingulum <0.05
−14 −12 67 L superior frontal gyrus <0.05 0 33 36 L superior frontal gyrus <0.05
−7 −11 71 Paracentral lobule <0.05 – – –
51 4- 34 R medial temporal gyrus <0.05 – – –
25 14 −40 R superior temporal gyrus <0.05 – – –
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under	 study,	 and	 its	measurement	 and	 not	 the	 validity	 of	 the	
findings.	VBM	is	also	not	a	particular	sensitive	tool	for	posterior	
fossa	analysis,	and	the	presence	of	LB	does	not	necessarily	imply	
measurable	 cortical	 volume	 change.	 Moreover,	 previous	 stud-
ies	 suggested	 that	 synaptic	 dysfunction	 can	 occur	without	 the	
presence	of	Lewy	bodies	per  se	 and	 that	using	 the	presence	of	
LB	to	measure	pathological	progression	might	not	be	enough	to	
predict	the	spread	of	disease	(34).
Nevertheless,	 the	 importance	 of	 these	 findings	 is	 clear.	
Pathology	 is	 far	 advanced	 throughout	 the	 brain	when	patients	
are	 actually	 diagnosed	 with	 the	 disease.	 Even	 though	 this	 has	
been	suggested	by	the	knowledge	and	identification	of	non-motor	
symptoms	in	the	premotor	phase	(35),	it	had	not	been	universally	
demonstrated	in	idiopathic	PD	(4).	This	is	a	fundamental	issue	
when	addressing	neuroprotective	therapies.	Since	cortical	areas	
are	involved	at	the	onset	of	motor	symptoms,	even	patients	with	
very	 early	 disease	may	 not	 be	 the	 ideal	 candidates	 for	 clinical	
studies.	The	process	of	brain	pathology	may	be	so	advanced	that	
those	therapies	may	no	longer	work,	or	possibly	longer	periods	
of	observation	would	be	necessary	 to	address	neuroprotection.	
Also,	PD	has	diverse	clinical	manifestations	and	possibly	different	
PD	subtypes	may	have	different	underlying	pathological	patterns.	
Future	studies	may	consider	studying	the	posterior	fossa	in	detail	
in	subjects	with	mild	or	very	early	disease,	such	as	the	SUIT	tool	
for	VBM	(36).
Since	our	study	is	a	cross-sectional	analysis	of	disease	stages,	
we	can	only	infer	progression	of	the	cerebral	involvement	as	the	
clinical	 manifestations	 worsens.	 Previous	 longitudinal	 studies	
using	 different	 imaging	 analysis	 have	 suggested	 that	 striatal	
atrophy	occurs	earlier	in	the	disease	process,	while	cortical	GM	
loss	 is	 restricted	 to	 later	 stages,	 reduced	 overall	 gyrification,	
and	 bilaterally	 in	 the	 inferior	 parietal,	 postcentral,	 precentral,	
superior	frontal,	and	supramarginal	areas	was	present	in	patients	
with	disease	 for	 less	 than	1 year,	and	 the	 rate	 loss	was	acceler-
ated	as	disease	progressed	(37).	Although	our	subjects	presented	
some	homogeneity	in	their	mean	clinical	scale	scores	per	group	
(with	lower	scores	in	the	mild	group,	intermediate	in	the	moder-
ate	 group,	 and	higher	 scores	 in	 the	 severe	 group	 in	 the	motor	
and	non-motor	scales),	we	classified	them	solely	based	on	their	
HY	score.	The	HY	is	a	well-accepted	scale,	as	it	correlates	with	
imaging	studies	of	dopamine	loss	and	with	quality	of	life,	motor	
impairment,	and	disability	scales	(38).	However,	it	does	not	offer	
TaBle 3 | areas with reduced functional connectivity in Parkinson’s disease patients when compared to healthy controls within clusters (p < 0.05).
cluster coordinate (x y z) networks areas with altered connectivity p-Value
16 −6 58 −2 Visual Parhippocampal gyrus <0.05
Lingual gyrus <0.05
Occipital pole <0.05
Superior parietal lobule <0.05
Precentral gyrus <0.05
Supramarginal gyrus <0.05
38 −3 10 34 Sensorimotor Thalamus <0.05
Insula <0.05
Superior temporal gyrus <0.05
Precentral gyrus <0.05
Inferior frontal gyrus <0.05
Middle frontal gyrus <0.05
Parietal lobule <0.05
Supramarginal gyrus <0.05
Cingulate Gyrus <0.05
66 0 −22 4 DMN Thalamus <0.05
Occipital lobe <0.05
Lingual gyrus <0.05
Anterior cingulate <0.05
Cingulate gyrus <0.05
Superior frontal gyrus <0.05
Superior temporal gyrus <0.05
69 0 −67 −14 Cerebellar Lingual gyrus <0.05
Thalamus <0.05
Cingulate Gyrus <0.05
Precentral gyrus <0.05
Frontal gyrus <0.05
Angular gyrus <0.05
Frontal pole <0.05
Occipital cortex <0.05
Brainstem <0.05
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any	direct	information	regarding	non-motor	issues.	It	should	be	
also	noted	that	the	age	in	the	groups	were	inadvertently	similar.	
We	did	not	pair	the	three	samples	based	on	age.	So,	more	severe	
subjects	had	longer	disease	duration	and	an	earlier	onset.	Patients	
with	earlier	onset	usually	have	a	less	aggressive	disease,	compared	
to	those	with	a	later	onset	(39).	It	has	been	previously	described	
that	brain	alteration	in	patients	with	earlier	onset	and	long	disease	
duration	fit	the	Braak’s	model,	while	in	patients	with	later	onset	
and	short	disease	duration	it	did	not	occur	(40).	Thus,	we	may	
have	underestimated	the	degree	of	atrophy	 in	the	severe	group	
and	 a	 longitudinal	 approach,	 taking	 age	 of	 onset	 and	 possibly	
clinical	subtypes	is	the	next	step	in	this	exploratory	study.
Functional	 connectivity	 was	 decreased	 within	 visual,	 sen-
sorimotor,	 DMN,	 and	 cerebellar	 networks.	 Although	 there	 is	
overwhelming	evidence	that	several	networks	are	altered	in	PD	
(41–43),	the	results	from	previous	studies	are	controversial.	The	
methods	used	are	as	diverse	as	the	results.	They	differ	in	subject	
samples,	type	of	MRI	analysis,	and	the	ROI	chosen,	making	them	
difficult	to	compare.	Most	studies	with	fMRI	use	the	independent	
component	analysis	(ICA)	technique,	which	is	based	on	the	theory	
that	the	fMRI	signal	of	each	voxel	represents	a	linear	mixture	of	
signals.	These	are	separated	by	statistical	analysis	of	independent	
signals,	and	finally,	the	brain	regions	with	the	same	independent	
signals	are	grouped	together	as	separate	components	(44).	ICA,	
however,	finds	functional	networks	in	data	randomly	generated,	
since	the	algorithm	used	is	an	optimization	procedure,	and	val-
ues	can	vary	due	to	the	chosen	threshold	and	variability	among	
patients	 (45).	 Conversely,	 the	 BASC	 method	 provides	 a	 fully	
automated	alternative	that	applies	to	an	arbitrarily	large	number	
of	networks	(22).	BASC	renders	more	robust	results	since	it	uses	
the	growth	region	to	find	networks	and	observes	the	replicability	
of	these	through	the	clusters	stability	analysis.
Unfortunately,	our	sample	was	relatively	small	and	heteroge-
neous,	and	we	were	unable	to	classify	the	subjects	into	the	same	
groups	in	the	rs-fMRI	analysis.	We	can	only	conclude	from	our	
analysis	 that	 there	 is	widespread	decreased	FC	 in	PD,	and	 this	
correlates	with	 the	 regions	 in	which	we	 observed	 atrophy	 and	
decreased	 CT	 in	 our	 structural	 analysis.	 Different	 patterns	 of	
reduced	 connectivity	 may	 explain	 differences	 in	 clinical	 pres-
entation	within	patients	with	PD,	 such	as	dyskinesias	 (46)	and	
behavioral	differences	(47).	In	the	future,	we	may	be	able	to	study	
the	pattern	of	FC	 in	 the	 individual	patient,	 and	 from	 the	 con-
figuration	observed,	there	is	a	chance	we	may	be	able	to	predict	
how	the	disease	will	progress,	or	select	individualized	targets	for	
neurosurgical	procedures.
cOnclUsiOn
In	 summary,	 we	 used	 validated,	 complementary,	 and	 well-
documented	 techniques	 to	 assess	 brain	 alterations	 in	 PD.	We	
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confirmed	that	subjects	with	mild	symptoms	already	have	corti-
cal	involvement	and	similar	regions	are	affected	both	structurally	
and	 functionally.	 Nevertheless,	 future	 longitudinal	 studies	 are	
needed	to	further	comprehend	all	the	mechanisms	contributing	
to	PD	and	its	clinical	subtypes.
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